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Abstract We present two patients with bothersome stress
urinary incontinence (SUI) following radical hysterectomy
and pelvic lymphadenectomy for early stage cervical
cancer. One patient underwent adjuvant radiotherapy. We
selected, after extensive counseling, TVT-Secur in these
two patients as we aimed to avoid the pelvic cavity,
expecting altered anatomy due to major pelvic surgery,
and counting on low risk of developing bladder retention,
given results of a case series. Both patients were continent
post-operatively. One patient presented with a small tape
erosion that was successfully corrected using local analge-
sics. The other patient developed urgency symptoms that
disappeared after treatment with solifenacine. Both patients
had detrusor hypo-activity at pre-operative urodynamics,
but no bladder retention occurred following surgery. In
patients with a history of radical hysterectomy who present
with SUI, we would advise to counsel that satisfying results
can be expected of TVT-Secur, although it is likely that
additional care after surgery is needed.
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Abbreviations
SUI stress urinary incontinence
RH radical hysterectomy
FIGO International Federation of Gynecology andObstetrics
PRV post-voiding residual bladder volume
UDI urogenital distress inventory
IIQ Incontinence Impact Questionnaire
TVT tension-free vaginal tape
Introduction
Radical hysterectomy is a known risk factor for the
development of stress urinary incontinence [1]. There is
limited evidence about managing SUI optimally in patients
treated for cervical cancer. The standard regimen of
prescribing supervised pelvic floor muscle training and
proposing a mid-urethral sling procedure if this fails, may
not work in this group of patients due to their unique
characteristics: (1) during radical hysterectomy autonomic
nerve damage results in hypo-activity of the detrusor
muscle, therefore, having increased risk of bladder retention
following surgery [1]; (2) adjuvant radiotherapy worsens
the quality of the vaginal mucosa due to fibrosis and
decreased vascularisation, resulting in increased erosion
risk [2]; (3) radiotherapy for cervical cancer can cause
detrusor overactivity.
Since the introduction of the TVT, it has been attempted
to reduce the morbidity of the procedure. The trans-
obturator technique offers an approach that avoids the
bladder region, resulting in less bladder lesions. Recently,
TVT-Secur has been introduced allowing vaginal introduc-
tion of a mid-urethral sling without passing the retro-pubic
space nor the obturator foramen and its related nerves and
vessels [3].
We selected TVT-Secur in the following two cases as we
aimed to avoid the pelvic cavity, expecting altered anatomy
due to extensive pelvic surgery, and counting on low risk of
developing bladder retention, given the first results of a
case series reporting low risk on bladder retention [3].
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Case reports
Patient A, a 52-year-old woman visited the uro-gynaecol-
ogy outpatient clinic with bothersome stress urinary
incontinence (SUI) and overactive bladder symptoms. Eight
months before, she underwent radical hysterectomy (RH)
with pelvic lymphadenectomy for cervical adenocarcinoma
FIGO stage IB-I. SUI was present before this treatment but
had become more severe afterwards. She reported no
defecation or sexual symptoms. She had two spontaneous
deliveries and was postmenopausal.
Pelvic examination revealed mild atrophy of the vaginal
mucosa. Pelvic organ prolapse was not observed. Urody-
namic investigation confirmed the presence of SUI and,
additionally, showed hypo-activity of the detrusor.
Pelvic physiotherapy failed after which the patient opted
for a mid-urethral sling procedure. She was counseled about
the increased risk on bladder retention, self-catheterization
and worsening of urgency. It was decided to perform TVT-
Secur, after a vaginal estrogen therapy of 4 weeks. The
procedure was performed with local analgesics and sedation
without complications.
Six hours after the procedure, the patient could not
empty the bladder. An indwelling bladder catheter was
replaced for 24 h, after which, the post-voiding residual
bladder volume (PRV) was 50 ml and the patient was
discharged.
A follow-up 6 weeks post-operatively showed large
reduction of SUI, but slight increase of urgency and
frequency. During pelvic examination, the tape appeared
to be localized at the level of the mid-urethra. There was a
PRV of 60 ml, no erosion and no urinary tract infection.
Three months after surgery, treatment with solifenacine
5 mg per day was started because of persistent urgency
symptoms. Six months post-operative, the patient had no
SUI and no overactive bladder symptoms.
Patient A completed the Urogenital Distress Inventory
(UDI) and Incontinence Impact Questionnaire (IIQ) before
surgery and 6 months after surgery [4]. Domain scores of
these questionnaires vary from 0 (minimal bother) to 100
(maximal bother). The score of the UDI incontinence
domain before and 6 months after surgery was 66 and 0,
respectively; of the UDI overactive bladder domain, 66 and
0, respectively; of the IIQ mobility domain, 89 and 44,
respectively; and of the IIQ emotional domain, 55 and 11,
respectively.
Patient B, a 44-year-old woman presented at the uro-
gynaecology outpatient clinic with progressive stress
urinary incontinence (SUI). Five years before, she under-
went radical hysterectomy and pelvic lymphadenectomy
because of cervical squamous cell carcinoma FIGO stage
IB-I. Adjuvant radiotherapy was administered because of
tumour invasion in the right parametrium. During a 5-
year follow-up, there had been no evidence of recurrent
disease.
Apart from bothersome SUI, she complained about
frequency. There were no urgency or urge-incontinence
symptoms. She did not report defecation symptoms. Her
sexual activity was limited due to decreased sexual arousal
since treatment of her malignancy. She had an obstetric
history of one uncomplicated delivery.
During pelvic examination, there was no sign of pelvic
organ prolapse or vaginal atrophy. During Valsalva ma-
noeuvre, urethral hyper-mobility and SUI were observed.
Urodynamic investigation confirmed the presence of SUI.
Bladder capacity was 690 ml and PVR was less than 50 ml.
There was hypo-activity of the detrusor muscle.
After extensive counseling, an uncomplicated TVT-Secur
procedure was performed. The patient was discharged the
same day after the PVR was confirmed to be less than 100 ml.
At the first follow-up visit 6 weeks after surgery, SUI
was no longer present. Examination revealed a mid-urethral
erosion of 10 by 10 ml. Initially vaginal estrogen therapy
was commenced resulting in reduction of the erosion but
not in complete closure. Then the erosion was surgically
closed using local analgesics after which vaginal estrogen
therapy was continued. A small erosion of 3 mm para-
urethral was observed 4 weeks after this second procedure.
This was cut away at the outpatient clinic and not observed
at follow-up visits afterwards.
Before surgery, the score of the UDI incontinence domain
was 66, of the UDI overactive bladder domain 33, of the IIQ
mobility domain 66 and of the IIQ emotional domain 33. Six
months after surgery, all these domain scores were 0.
Discussion
The overactive bladder symptoms in patient A may be
related to previous radical hysterectomy, but could also be
the result of post-operative cystitis that could have occurred
in any patient [5]. The erosion in patient B can be explained
by poor tissue quality due to previous radiotherapy as, after
closure, a second erosion occurred.
Both patients were satisfied with the result of TVT-Secur
despite the fact that additional treatment was needed for
unwanted side effects.
Conclusion
This case report shows that TVT-Secur is a valuable
treatment option in patients treated for cervical cancer
who present with bothersome SUI. We advise to counsel
patients that a satisfying result can be expected but that it
is also likely that additional care after surgery is needed.
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